Aortic dissection in a patient treated with anlotinib for metastatic lung squamous cell carcinoma

Anlotinib is an anti‐angiogenic drug that targets vascular endothelial growth factor receptor, platelet‐derived growth factor receptor, fibroblast growth factor receptor, c‐Kit, and other kinases and has been approved for the treatment of advanced non‐small cell lung cancer (NSCLC). As in other smal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Bailing, Li, Junhe, Chen, Jun, Xiang, Xiaojun, Xiong, Jianping, Deng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996977/
https://www.ncbi.nlm.nih.gov/pubmed/31891239
http://dx.doi.org/10.1111/1759-7714.13288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996977/
https://www.ncbi.nlm.nih.gov/pubmed/31891239
http://dx.doi.org/10.1111/1759-7714.13288

Ejemplares similares